John A. Steinharter
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Diagnosis and Treatment, Systemic Sclerosis and Related Diseases, Renal cell carcinoma treatment, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study(2020)1,787 cited
- → Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma(2020)987 cited
- → Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma(2021)602 cited
- → Progressive immune dysfunction with advancing disease stage in renal cell carcinoma(2021)492 cited
- → Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes(2020)284 cited
- → Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma(2018)258 cited
- → Transcriptional mediators of treatment resistance in lethal prostate cancer(2021)187 cited
- → Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma(2021)156 cited
- → Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features(2019)143 cited
- → Integrative clinical and molecular characterization of translocation renal cell carcinoma(2022)112 cited